Insights

All Categories

18 July 2013

OneVentures

Smart Sparrow wins silver at Learning Impact 2013, San Diego


15 July 2013

OneVentures

Incoming nominated for Ground Breaker Award for Engineering Excellence at SPIFFY 2013


02 July 2013

OneVentures

Smart Sparrow initiative receives government funding boost


12 June 2013

OneVentures

Vaccines via a patch: Mark Kendall at TEDGlobal 2013


02 May 2013

OneVentures

NICTA’s ‘Incoming’ mobile video start-up company switches on with $1.1M in seed financing


15 April 2013

OneVentures

Taking the next step beyond MOOCs


11 April 2013

OneVentures

OneVentures team ‘charmed’ by Queensland Health-IT company


26 March 2013

OneVentures

Start-ups swimming in venture capital


17 March 2013

OneVentures

Vaxxas recogniseds as 2013 BioSpectrum Asia-Pacific Emerging Company of the Year


13 March 2013

OneVentures

TheBestDay closes $1million dollar funding round


12 March 2013

OneVentures

Hugh Alsop appointed Hatchtech CEO


27 February 2013

OneVentures

Who’s disrupting your industry? Meet 10 start-ups eager to eat the big boys’ lunch


27 November 2012

OneVentures

Hatchtech publish data on Head Lice treatment safety study and mechanism of action


30 October 2012

OneVentures

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012


25 October 2012

OneVentures

Novel Pediculicide Clears Most Head Lice With 1 Application


25 October 2012

OneVentures

Smart Sparrow a winner at Tech23


23 October 2012

OneVentures

Smart Sparrow a winner at Tech23 2012


08 October 2012

OneVentures

Vaxxas Appoints David Hoey as Company’s First CEO


08 October 2012

OneVentures

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation


03 September 2012

OneVentures

Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™


08 August 2012

Virtual patient gets funding injection


08 August 2012

Garrett acts out NBN potential


15 July 2012

Digital tools can reshape our methods


17 April 2012

Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards